Park National Corp Abb Vie Inc. Transaction History

Park National Corp

$2.82 Billion
Q3 2024

A detailed history of Park National Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Park National Corp holds 138,634 shares of ABBV stock, worth $25 Million. This represents 0.97% of its overall portfolio holdings.

Number of Shares

138,634

Previous 146,099 5.11%

Holding current value

$25 Million

Previous $25.1 Million 9.25%

% of portfolio

0.97%

Previous 0.94%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 01, 2024	SELL	$163.84 - $199.33 $1.22 Million - $1.49 Million	-7,465 Reduced 5.11%	138,634 $27.4 Million
Q2 2024 Jul 15, 2024	BUY	$154.79 - $180.76 $1.81 Million - $2.11 Million	11,673 Added 8.68%	146,099 $25.1 Million
Q1 2024 Apr 01, 2024	SELL	$159.82 - $182.1 $1.72 Million - $1.96 Million	-10,771 Reduced 7.42%	134,426 $24.5 Million
Q4 2023 Jan 02, 2024	SELL	$137.6 - $154.97 $916,828 - $1.03 Million	-6,663 Reduced 4.39%	145,197 $22.5 Million
Q3 2023 Oct 02, 2023	BUY	$133.59 - $154.65 $440,179 - $509,571	3,295 Added 2.22%	151,860 $22.6 Million
Q2 2023 Jul 03, 2023	BUY	$132.51 - $164.9 $1.05 Million - $1.3 Million	7,907 Added 5.62%	148,565 $20 Million
Q1 2023 Apr 03, 2023	BUY	$144.61 - $166.54 $5.76 Million - $6.63 Million	39,840 Added 39.52%	140,658 $22.4 Million
Q4 2022 Feb 06, 2023	SELL	$138.31 - $165.87 $1.23 Million - $1.48 Million	-8,921 Reduced 8.13%	100,818 $16.3 Million
Q3 2022 Oct 03, 2022	BUY	$134.21 - $153.93 $4.52 Million - $5.18 Million	33,673 Added 44.27%	109,739 $14.7 Million
Q2 2022 Jul 01, 2022	SELL	$137.62 - $174.96 $325,884 - $414,305	-2,368 Reduced 3.02%	76,066 $11.7 Million
Q1 2022 Apr 01, 2022	SELL	$131.98 - $163.75 $904,194 - $1.12 Million	-6,851 Reduced 8.03%	78,434 $12.7 Million
Q4 2021 Jan 04, 2022	SELL	$107.43 - $135.93 $1.79 Million - $2.27 Million	-16,698 Reduced 16.37%	85,285 $11.5 Million
Q3 2021 Oct 01, 2021	SELL	$106.4 - $120.78 $614,460 - $697,504	-5,775 Reduced 5.36%	101,983 $11 Million
Q2 2021 Jul 01, 2021	SELL	$105.21 - $117.21 $1.18 Million - $1.32 Million	-11,248 Reduced 9.45%	107,758 $12.1 Million
Q1 2021 Apr 01, 2021	SELL	$102.3 - $112.62 $3.17 Million - $3.49 Million	-30,965 Reduced 20.65%	119,006 $12.9 Million
Q4 2020 Jan 04, 2021	SELL	$80.49 - $108.67 $944,952 - $1.28 Million	-11,740 Reduced 7.26%	149,971 $16.1 Million
Q3 2020 Oct 01, 2020	SELL	$85.91 - $100.83 $2.81 Million - $3.3 Million	-32,680 Reduced 16.81%	161,711 $14.2 Million
Q2 2020 Jul 01, 2020	SELL	$73.37 - $98.18 $844,635 - $1.13 Million	-11,512 Reduced 5.59%	194,391 $19.1 Million
Q1 2020 Apr 01, 2020	SELL	$64.5 - $97.79 $1.14 Million - $1.74 Million	-17,746 Reduced 7.93%	205,903 $15.7 Million
Q4 2019 Jan 02, 2020	SELL	$72.13 - $90.25 $976,712 - $1.22 Million	-13,541 Reduced 5.71%	223,649 $19.8 Million
Q3 2019 Oct 01, 2019	SELL	$62.98 - $75.72 $4.31 Million - $5.19 Million	-68,495 Reduced 22.41%	237,190 $18 Million
Q2 2019 Jul 01, 2019	BUY	$65.7 - $83.98 $359,510 - $459,538	5,472 Added 1.82%	305,685 $22.2 Million
Q1 2019 Apr 01, 2019	BUY	$77.14 - $90.79 $1.15 Million - $1.35 Million	14,906 Added 5.22%	300,213 $24.2 Million
Q4 2018 Jan 02, 2019	BUY	$77.85 - $96.01 $1.21 Million - $1.49 Million	15,569 Added 5.77%	285,307 $26.3 Million
Q3 2018 Oct 02, 2018	BUY	$88.91 - $98.84 $466,332 - $518,415	5,245 Added 1.98%	269,738 $25.5 Million
Q2 2018 Jul 02, 2018	BUY	$89.78 - $106.23 $591,021 - $699,312	6,583 Added 2.55%	264,493 $24.5 Million
Q1 2018 Apr 02, 2018	SELL	$92.01 - $123.21 $1.7 Million - $2.27 Million	-18,426 Reduced 6.67%	257,910 $24.4 Million
Q4 2017 Jan 02, 2018	SELL	$89.56 - $98.21 $1.29 Million - $1.42 Million	-14,447 Reduced 4.97%	276,336 $26.7 Million
Q3 2017 Oct 02, 2017	BUY	$69.85 - $89.22 $20.3 Million - $25.9 Million	290,783	290,783 $25.8 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Park National Corp , based on Form 13F filings with the SEC.

News

Stay updated on Park National Corp with notifications on news.

Account

Park National Corp Abb Vie Inc. Transaction History